SCHEMBL8669601

SCHEMBL8669601

[CH](Cc1ccc2cn[nH]c2c1)c1ccc2cn[nH]c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 3/20 0.46
MAPT P10636 3/20 0.46
DYRK1A Q13627 2/20 0.46
METAP2 P50579 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
PKM P14618 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
NEK2 P51955 2/20 0.44
INSR P06213 2/20 0.43
IGF1R P08069 2/20 0.43
FGFR1 P11362 5/20 0.42
APP P05067 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
FGFR2 P21802 2/20 0.41
FGFR3 P22607 1/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8713967 0.88 FGFR1 (0.51) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL8666607 0.84 MAPK1 (0.51) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL17584956 0.78 NOS1 (0.58) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL29569662 0.78 NOS1 (0.53) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL578417 0.78 NOS1 (0.53) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL3803624 0.77 MAPT (0.50) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL8669605 0.77 NOS1 (0.57) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL13550141 0.74 MAPT (0.53) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL20721588 0.74 NOS1 (0.53) NOS1MAPTDYRK1AMETAP2KDM4E
SCHEMBL20721589 0.74 MAPT (0.53) NOS1MAPTDYRK1AMETAP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed
EP-0686151-A1 SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-12-13 EP disclosed